Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyrilutamide solution in Chinese adult women with androgenetic alopecia (Phase II)
CTR20212684Phase 2Completed
- Sponsor
- Suzhou Kaixi Pharmaceutical
- Start
- Nov 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pyrilutamide in androgenetic alopecia (AGA), sponsored by Suzhou Kaixi Pharmaceutical. Started Nov 2021; status: completed.
02
Drugs
pyrilutamide
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on CTR20212684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212684.